Lazarex Cancer Foundation is located in Danville, CA. The organization was established in 2006. According to its NTEE Classification (B90) the organization is classified as: Educational Services, under the broad grouping of Education and related organizations. As of 12/2023, Lazarex Cancer Foundation employed 23 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lazarex Cancer Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Lazarex Cancer Foundation generated $3.7m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 5.2% each year. All expenses for the organization totaled $6.2m during the year ending 12/2023. While expenses have increased by 11.9% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Lazarex Cancer Foundation has awarded 24 individual grants totaling $3,317,795. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
FINANCIAL ASSISTANCE FOR CANCER PATIENTS TO DEFRAY THE COSTS OF FDA APPROVED CLINICAL TRIALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
LAZAREX CARE PROGRAM: THIS PROGRAM FOCUSES ON IMPROVING THE OUTCOME OF CANCER CARE FOR ADVANCED STAGE CANCER PATIENTS AND THE MEDICALLY UNDERSERVED BY IDENTIFYING FDA CLINICAL TRIAL OPTIONS, PROVIDING ASSISTANCE WITH OUT-OF-POCKED TRAVEL EXPENSES FOR CLINICAL TRIAL PARTICIPATION AND A TRAVEL COMPANION IF NEEDED, AND BY FACILITATING COMMUNITY OUTREACH AND ENGAGEMENT. IN 2023, WE ASSISTED 1236 PATIENTS WITH THIS PROGRAM, AN INCREASE OF 28% OVER 2022. WE CONTINUE TO INCREASE RACIAL AND ETHNIC DIVERSITY OF PARTICIPANTS IN THIS PROGRAM, ACHIEVING 37%, WHILE THE NATIONAL AVERAGE IN CANCER CLINICAL TRIALS AT ABOUT 5%. 30% OF PATIENTS ASSISTED CAME FROM HOUSEHOLDS EARNING LESS THAN $25,000 ANNUALLY.
LAZAREX CANCER WELLNESS HUB PROGRAM: LAZAREX CANCER WELLNESS HUBS OPERATED IN PHILADELPHIA THROUGH DREXEL UNIVERSITY AND PENN ABRAMSON, IN LOS ANGELES THROUGH USC NORRIS, AND IN THE SAN FRANCISCO EAST BAY AREA IN COLLABORATION WITH MONUMENT CRISIS CENTER. THE GOAL OF THE LAZAREX CANCER WELLNESS HUB PROGRAM IS TO GENERATE A REPLICABLE PROGRAM THAT IS PLACE BASED, CULTURALLY APPROPRIATE, AND COMMUNITY DRIVEN, THAT OPERATES IN AT-RISK COMMUNITIES OF COLOR ACROSS THE CONTINUUM OF CANCER CARE TO IMPROVE CANCER HEALTH DISPARITIES AND IMPROVE CANCER HEALTH OUTCOMES.
LAZAREX IMPACT PROGRAM: THE GOAL OF IMPACT IS TO GENERATE A SUSTAINABLE PROOF OF CONCEPT ACTION PLAN TO TRANSFORM THE STATUS QUO OF CLINICAL TRIAL RECRUITMENT, ENROLLMENT, RETENTION, MINORITY PARTICIPATION, COMPLETION, AND TRANSLATIONAL SCIENCE, MOST IMPORTANTLY PROVIDING EQUITABLE AND TIMELY ACCESS TO CANCER DISCOVERY FOR ALL PATIENTS. IN 2023, IMPACT WAS IN OPERATION AT PENN ABRAMSON, UTSW, USOR, AND MD ANDERSON COMPREHENSIVE CANCER CENTER. IN 2023 WE SERVED 602 PATIENTS IN THIS PROGRAM, WITH 37% MINORITY PARTICIPATION, AND 25% FROM HOUSEHOLDS EARNING LESS THAN $25,000 ANNUALLY.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Stephanie Rivera Thru 1123 CEO | Officer | 40 | $215,982 |
Clay Jackson Chairman | OfficerTrustee | 2 | $0 |
Kenny J Simansky Vice President | OfficerTrustee | 2 | $0 |
Kwame Boateng CFO | OfficerTrustee | 2 | $0 |
Darlene Chiang Secretary | OfficerTrustee | 2 | $0 |
Dr Frank Crnkovich Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $407,561 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $3,134,993 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $3,542,554 |
Total Program Service Revenue | $0 |
Investment income | $149,292 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$817 |
Net Income from Fundraising Events | -$23,095 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,734,815 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,105,979 |
Grants and other assistance to domestic individuals. | $3,310,867 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $232,740 |
Compensation of current officers, directors, key employees. | $46,548 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $869,715 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $100,400 |
Payroll taxes | $89,971 |
Fees for services: Management | $0 |
Fees for services: Legal | $473 |
Fees for services: Accounting | $70,151 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $73,947 |
Advertising and promotion | $88,364 |
Office expenses | $10,713 |
Information technology | $73,336 |
Royalties | $0 |
Occupancy | $105,730 |
Travel | $14,334 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $2,350 |
All other expenses | $13,070 |
Total functional expenses | $6,230,037 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $246,062 |
Savings and temporary cash investments | $3,068,940 |
Pledges and grants receivable | $198,509 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $941 |
Net Land, buildings, and equipment | $10,476 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $615,641 |
Other assets | $8,969 |
Total assets | $4,149,538 |
Accounts payable and accrued expenses | $496,059 |
Grants payable | $0 |
Deferred revenue | $446,380 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $631,445 |
Total liabilities | $1,573,884 |
Net assets without donor restrictions | $66,954 |
Net assets with donor restrictions | $2,508,700 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $4,149,538 |
Over the last fiscal year, Lazarex Cancer Foundation has awarded $1,105,979 in support to 9 organizations.
Grant Recipient | Amount |
---|---|
DREXEL UNIVERSITY | | | $245,278 |
CENTER FOR HUMAN DEVELOPMENT | | | $34,869 |
MONUMENT CRISIS CENTER | | | $30,329 |
PENN ABRAMSON | | | $175,610 |
MONUMENT IMPACT | | | $34,869 |
UNIV OF TEXAS MD ANDERSON | | | $87,065 |